CN204813902U - Implanted cancer recurring real -time monitoring system - Google Patents
Implanted cancer recurring real -time monitoring system Download PDFInfo
- Publication number
- CN204813902U CN204813902U CN201520501397.2U CN201520501397U CN204813902U CN 204813902 U CN204813902 U CN 204813902U CN 201520501397 U CN201520501397 U CN 201520501397U CN 204813902 U CN204813902 U CN 204813902U
- Authority
- CN
- China
- Prior art keywords
- circulation
- rna
- free
- monitoring system
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The utility model discloses an implanted cancer recurring real -time monitoring system, this monitoring system include internal implantation subassembly and external subassembly, and the digital information of transmissible is responsible for changing the concentration information of the free nucleic acid of the mark of the cancer in the tissue fluid - circulation into by internal implantation subassembly, and external subassembly is responsible for showing the alarm that erupts simultaneously out with received digital information, reminds the cancer recurring probably to take place. The utility model discloses an implanted cancer recurring real -time monitoring system can the real -time supervision cancer the recurring condition, make the patient of cancer recurring can obtain timely treatment.
Description
Technical field
This utility model belongs to medical instruments field, relates to a kind of cancer return monitoring system, is specifically related to a kind of implanted cancer return real-time monitoring system.
Background technology
The curative competence of current China cancer is also not fully up to expectations, and in whole cancer patient, nearly 1/3 can be cured, and obtains the chance of long term survival, but also has the cancer patient about half to occur relapse and metastasis in the course of disease.Cancer return refers to that the cancer be brought under control occurs again on former hair device official, or cancer invades lymph vessels or body cavity from original site, moves to elsewhere continued growth, forms the tumor with primary tumor same-type.Some cancer can first treatment after some months or recur after several years.Therefore for cancer patient, the monitoring carrying out postoperative recurrence transfer is very important.The sign of cancer return transfer find more early, just can take counter-measure in time, the probability that effective suppression cancer return shifts, the life cycle that prolongation cancer patient is postoperative.
The free RNA (circulatingcell-freenucleicacids) of circulation refers to and is present in human recycle system, be free on extracellular micro-endogenous or Exogenous Nucleic Acid fragment, comprise core DNA, mitochondrial DNA (mitochondrialDNA, mitDNA), viral DNA, messenger RNA (messengerRNA, and Microrna (microRNA, circulation free RNA) etc. mRNA).The stability of mRNA itself is lower, and the RNA enzyme level simultaneously in tumor patient blood raises, and therefore previously think that circulation free mRNA degradation speed is very fast, clinical value is limited.Have research to be disclosed in the serum of tumor patient, RNA exists with the form of fat egg from complex.Separately studies have found that, free mRNA multi-source, in apoptosis, is present in apoptotic body, and the free mRNA stability therefore in tumor patient blood is higher.These features all make free mRNA detect to be applied to and clinically become possibility.Research finds, can detect that the overall survival of the patient of cyclinD1mRNA is starkly lower than the patient of blood plasma cyclinD1mRNA feminine gender in the blood plasma of patient with breast cancer; In the good patient of clinical pathologic characteristic prompting prognosis, the patient's prognosis detecting cyclinD1mRNA in blood plasma is poor; In the patient of his silent former times sweet smell treatment, the overall survival of the patient of the blood plasma cyclinD1mRNA positive is starkly lower than the patient of cyclinD1mRNA feminine gender.In addition, research finds that plasma of patients with nasopharyngeal carcinoma mRNA integrity reduces, and after radiotherapy, plasma free mRNA integrity obviously rises, and the free mRNA level of rising can be used as the index of disease amelioration.Above-mentioned achievement in research shows that mRNA free in blood can become the molecular marker of early diagnosis of cancer, relapse and metastasis monitoring.
MiRNA has important function in gene expression, post-transcriptional control, and may play the effect of proto-oncogene or antioncogene.They have high stability in plasma or serum, and with the generation of tumor, develop closely related, these speciality free RNA that makes to circulate becomes a kind of potential tumor markers.In kinds of tumors blood samples of patients, having found the abnormal change of the free rna level of circulation at present.MiR-155, miR-202, miR-425, miR-302b and miR-125b etc. are that expressing in healthy population and plasma of breast cancer patients or serum of reporting in recent years has the circulation of notable difference to dissociate RNA, in the early screening of breast carcinoma, have potential value; In addition, the level of miR-115 in hormone-sensitive and the insensitive blood serum of patients with human breast carcinoma of hormone is variant, and miR-10b level in the patients serum of estrogen receptor negative raises.For colorectal cancer patients, during miR-92a detects in early days, embody higher sensitivity; The rising of miR-21, the reduction of miR34a also have higher diagnosis effect; MiR-141 with miR-221 is then considered to relevant to poor prognosis.
The mode of current patient monitoring cancer return mainly regularly arrives hospital and checks, and this mode is for patient, and one is inconvenient, and expend time in, two is check not in time, likely misses the probability of early discovery cancer return.Conveniently cancer patient can check oneself the recurrence of cancer timely, study a kind of can Real-Time Monitoring cancer patient recurrence equipment be necessary.
Prior art to show in blood that the free circulation RNA that dissociates can be used as the potential source biomolecule label detecting all kinds of cancer and disease, for the earlier detection of patient's peripheral blood cancer and the detection of cancer return.Tissue fluid is that blood plasma filters from capillary wall and formed, and except not containing except macro-molecular protein, other composition is basic identical with blood plasma.Therefore the free circulation existed in the blood RNA that dissociates exists equally in tissue fluid, and namely the level therefore by detecting the free RNA of free circulation in tissue fluid can be used for the earlier detection of cancer and the detection of cancer return, acts on same blood the same.
Advantage of the present utility model and beneficial effect:
1, whether implanted cancer return real-time monitoring system of the present utility model is judged that cancer patient is postoperative recurred by the circulation detected in the tissue fluid rna level that dissociates, the diagnosis of molecular level can be able to find in early days in recurrence, provides diagnostic base for taking corresponding treatment means effectively and timely.
2, implanted cancer return real-time monitoring system of the present utility model can realize monitoring anywhere or anytime, reaches the object of real-time dynamic monitoring, and cancer patient can be made to grasp the current intelligence of cancer return transfer easily timely.
3, implanted cancer return real-time monitoring system of the present utility model is a monitoring system that can reuse, this monitoring system realizes the unlatching of monitoring system or the switching of resting state by the dissociate charging property of RNA sensor of controlled circulation, avoids the operation often detecting and once need again to implant monitoring system afterwards.
Summary of the invention
In order to solve the deficiencies in the prior art, the purpose of this utility model is to provide a kind of implanted cancer return real-time monitoring system, and described monitoring system completes the monitoring to cancer return by the level of the free RNA of circulation in monitoring skin undertissue liquid.Described monitoring system arranges the threshold value of a free RNA of circulation, when the circulation detected dissociate the level of RNA reach or exceed this threshold value time, described monitoring system then can notify by the mode given the alarm that monitoring system wearer cancer return may occur, cancer patient just can arrive hospital in time and make a definite diagnosis, and enables the state of an illness obtain control early.
To achieve these goals, this utility model takes following technical scheme:
This utility model provides a kind of implanted cancer return real-time monitoring system, and described cancer return real-time monitoring system comprises et al. Ke assembly 1 and external assembly 2, described et al. Ke assembly 1 comprises circulation free RNA sensor 11, data processing module 12, first wireless communication module 13, described data processing module 12 comprises input interface 121, microprocessor 122, output interface 123, reactor 124, described input interface 121 receive described circulation dissociate RNA sensor 11 export electrochemical signals and input described microprocessor 122 after it is converted into digital signal, be uploaded to described external assembly 2 by described output interface 123 via described first wireless communication module 13 after described microprocessor 122 pairs of digital signals carry out protocol conversion, described external assembly 2 comprises data receiver 21, and described data receiver 21 comprises controller 211, display 212, siren 213, second wireless communication module 214, described controller 211 receives and analyzes circulation that described et al. Ke assembly 1 uploads and to dissociate RNA signal, afterwards free for circulation RNA information is sent on display 212 and shows, the analysis programme of described controller 211 arranges a threshold value, when this threshold value of horizontal exceeding of the free RNA that circulates, described controller 211 sends instruction to described siren 213, described siren 213 gives the alarm, notify that wearer notes the danger of cancer return, the control command of described controller 211 passes on the described reactor 124 in described et al. Ke assembly 1 by described second wireless communication module 214, described reactor 124 controls described circulation and to dissociate the unlatching of RNA sensor 11 or resting state, when described circulation dissociates 11 dormancy of RNA sensor, the free RNA sensor 11 of circulation is with negative electricity, association reaction is there is not with the RNA that dissociates of the circulation with negative electricity, when described circulation dissociate RNA sensor 11 open time, the described circulation RNA sensor 11 that dissociates is not charged, association reaction is there is with the RNA that dissociates of the circulation with negative electricity, the electronegative circulation RNA that dissociates causes the dissociate electrical conductivity of RNA sensor 11 of described circulation to change, thus the concentration information of free for circulation RNA is converted into electrochemical signals.
Further, described external assembly 2 also comprises intelligent mobile terminal equipment 22, described data receiver 21 also comprises the 3rd wireless communication module 215, and free for circulation RNA information is sent in described intelligent mobile terminal equipment 22 by described 3rd wireless communication module 215 by described controller 211.
Described intelligent mobile terminal equipment 22 can be smart mobile phone, flat board or computer.
Further, described siren 213 is vibrators, notifies that wearer notes the danger of cancer return by the mode of vibration.
Further, described siren 213 is luminous organs, notifies that wearer notes the danger of cancer return by the mode of luminescence.
Further, the described circulation RNA sensor 11 that dissociates comprises circulation free RNA trapping layer 111, hybridization signal inductive layer 112.Described circulation RNA trapping layer 111 of dissociating sticks on described hybridization signal inductive layer 112.Described circulation RNA trapping layer 111 of dissociating is made up of the capture probe with the free RNA specific binding of circulation.
This utility model use with the capture probe of the free RNA specific binding of circulation can be DNA, RNA, peptide nucleic acid(PNA) or lock nucleic acid, as long as this probe can to dissociate RNA specific binding with circulation.Circulation for known array dissociates RNA, and the capture probe that those skilled in the art are hybridized with it according to the free RNA sequential design of circulation is routine techniques.Preferably, described capture probe is peptide nucleic acid(PNA) (PNA).
The nucleic acid analog of PNA to be a class with many phthaleins amine chain replace ribose (or deoxyribose) phosphate backbone, have Stability Analysis of Structures, not by nuclease and proteasome degradation, can the feature such as, electric neutrality low with base complementrity mode and single nucleic acid strands, cytotoxicity.PNA and DNA, RNA have stronger adhesion, have good specificity and higher sensitivity, and make PNA-DNA due to its electroneutral character, the double-strand of PNA-RNA is more stable, as compared to corresponding DNA-DNA, DNA-RNA double-strand, there is higher melting temperature.Due to the structural stability of PNA, make it can in number of chemical reagent stable existence, can stably be present in the wider temperature range of sour environment neutralization.Therefore, in the molecular hybridization that PNA can be widely used in pathogen, heredopathia detects, in situ hybridization, mutation analysis, anticancer, antiviral antisense nucleic acids research and application.
Further, described hybridization signal inductive layer 112 comprises by silicon nanowire array.Described hybridization signal inductive layer 112 is on the silicon nanowires utilizing conventional semiconductors technology to process, and is prepared from by silylation modification, surperficial unimolecule rete self assembly operation, fixes can form described circulation and to dissociate RNA sensor through capture probe.The preparation process of the free RNA sensor of circulation is well known to those skilled in the art.
Further, described first wireless communication module 13, described second wireless communication module 214, described 3rd wireless communication module 215 adopt any one in Bluetooth protocol or Zigbee protocol.
Further, described data receiver 12 can be worn at any part on cancer patient's health, is preferably worn in wrist.In addition, described data receiver 12 also can not be worn on a certain position of health of cancer patient, but uses as in vitro accessory.
Further, described controller 211 timing realizes the free unlatching of RNA sensor of circulation or the control of dormancy.The interval time of continuously adjustabe between 1s to 1800s that control command is assigned, adjustment stepping is 2s.
Can be used for the dissociate kind of RNA of circulation of the present utility model is that the circulation that there is significant correlation between those and cancer to be detected dissociates RNA, and the concentration namely by detecting the free RNA of circulation can judge whether whether cancer recurs.The free RNA of circulation comprises circulation free mRNA, the free miRNA of circulation.
Preferably, the free RNA of circulation is the free miRNA of circulation.
The using method of implanted cancer return real-time monitoring system of the present utility model:
First, control described implanted cancer return real-time monitoring system by described controller 211 and be in resting state, et al. Ke assembly, with negative electricity (institute is electrically charged atomic weak, can not damage human body), is implanted subcutaneous by the free RNA sensor 11 of now circulation;
Secondly, open described implanted cancer return real-time monitoring system by described controller 211, make the circulation RNA sensor 11 that dissociates not charged, the RNA that dissociates of the circulation now in tissue fluid can be combined with the free RNA sensor 11 of circulation;
Finally, after reaction certain hour, close implanted cancer return real-time monitoring system by described controller 211 to make it again to be in resting state, the free RNA sensor 11 of now circulation is with negative electricity, the circulation combined with circulation free RNA sensor 11 in tissue fluid RNA and the circulation RNA sensor 11 that dissociates that dissociates is separated, and described implanted cancer return real-time monitoring system is that detection is next time ready.
Cancer patient is dissociated by the circulation on observation display 212 reaction of RNA information and siren 213, knows whether cancer recurs.
Accompanying drawing explanation
Fig. 1 shows a kind of structural representation of implanted cancer return real-time monitoring system of the present utility model;
Fig. 2 shows a kind of structural representation of implanted cancer return real-time monitoring system of the present utility model;
Fig. 3 shows circulation of the present utility model and to dissociate the structural representation of RNA sensor;
Wherein, 1: et al. Ke assembly; 11: the free RNA sensor of circulation; 111: the free RNA trapping layer of circulation; 112: hybridization signal inductive layer; 12: data processing module; 121: input interface; 122: microprocessor; 123: output interface; 124: reactor; 13: the first wireless communication modules; 2: external assembly; 21: data receiver; 211: controller; 212: display; 213: siren; 214: the second wireless communication modules; 215: the three wireless communication modules; 22: intelligent mobile terminal equipment.
Detailed description of the invention
Below in conjunction with specific embodiment, illustrate this utility model further.Should be understood that these embodiments are only not used in restriction scope of the present utility model for illustration of this utility model.
Embodiment 1 one kinds of implanted cancer return real-time monitoring systems
A kind of implanted cancer return real-time monitoring system, cancer return real-time monitoring system comprises et al. Ke assembly 1 and external assembly 2, et al. Ke assembly 1 comprises circulation free RNA sensor 11, data processing module 12, first wireless communication module 13, data processing module 12 comprises input interface 121, microprocessor 122, output interface 123, reactor 124, input interface 121 receives electrochemical signals that the free RNA sensor 11 of circulation exports and input microprocessor 122 after it being converted into digital signal, is uploaded to external assembly 2 after microprocessor 122 pairs of digital signals carry out protocol conversion by output interface 123 via the first wireless communication module 13, external assembly 2 comprises data receiver 21, and data receiver 21 comprises controller 211, display 212, siren 213, second wireless communication module 214, controller 211 receives and analyzing body is implanted into circulation that assembly 1 uploads dissociates RNA signal, afterwards free for circulation RNA information is sent on display 212 and shows, the analysis programme of controller 211 arranges a threshold value, when this threshold value of horizontal exceeding of the free RNA that circulates, controller 211 sends instruction to described siren 213, siren 213 gives the alarm, notify that wearer notes the danger of cancer return, the control command of controller 211 passes on the reactor 124 in et al. Ke assembly 1 by the second wireless communication module 214, reactor 124 controlled circulation dissociates the unlatching of RNA sensor 11 or resting state, when dissociating 11 dormancy of RNA sensor when circulating, the free RNA sensor of circulation is with negative electricity, association reaction is there is not with the RNA that dissociates of the circulation with negative electricity, when the free RNA sensor 11 that circulates is opened, the free RNA sensor 11 of circulation is not charged, association reaction is there is with the RNA that dissociates of the circulation with negative electricity, electronegative circulation RNA cause the circulating electrical conductivity of free RNA sensor 11 of dissociating changes, thus the concentration information of free for circulation RNA is converted into electrochemical signals.
Siren 213 is vibrators, notifies that wearer notes the danger of cancer return by the mode of vibration.
The described circulation RNA sensor 11 that dissociates comprises circulation free RNA trapping layer 111, hybridization signal inductive layer 112.Described circulation RNA trapping layer 111 of dissociating is made up of the capture probe with the free RNA specific binding of circulation.Capture probe is peptide nucleic acid(PNA) (PNA).
Hybridization signal inductive layer 112 comprises silicon nanowire array.Hybridization signal inductive layer 112 is on the silicon nanowires utilizing conventional semiconductors technology to process, and is prepared from by silylation modification, surperficial unimolecule rete self assembly operation, fixes to form the free RNA sensor 11 of circulation through capture probe.The preparation process of the free RNA sensor 11 of circulation is well known to those skilled in the art.
First wireless communication module 13, second wireless communication module 214 adopts Bluetooth protocol.
Data receiver 12 can be worn at any part on cancer patient's health, such as, be worn in wrist.
Controller 211 timing realizes the free unlatching of RNA sensor of circulation or the control of dormancy.The interval time of continuously adjustabe between 1s to 1800s that control command is assigned, adjustment stepping is 2s.
Circulation in the present embodiment RNA that dissociates refers to miRNA.
The using method of above-mentioned implanted cancer return real-time monitoring system:
1, control implanted cancer return real-time monitoring system by controller 211 and be in resting state, et al. Ke assembly, with negative electricity (institute is electrically charged atomic weak, can not damage human body), is implanted subcutaneous by the free RNA sensor 11 of now circulation;
2, open implanted cancer return real-time monitoring system by controller 211, make the circulation RNA sensor 11 that dissociates not charged, the RNA that dissociates of the circulation now in tissue fluid can be combined with the free RNA sensor 11 of circulation;
3, after reacting certain hour, close implanted cancer return real-time monitoring system by controller 211 to make it again to be in resting state, the free RNA sensor 11 of now circulation is with negative electricity, the circulation combined with circulation free RNA sensor 11 in tissue fluid RNA and the circulation RNA sensor 11 that dissociates that dissociates is separated, and implanted cancer return real-time monitoring system is that detection is next time ready.
Whether 4, vibrated by dissociate RNA information and siren of the circulation of display on observation display 212, cancer patient knows whether cancer recurs.
Embodiment 2 one kinds of implanted cancer return real-time monitoring systems
A kind of implanted cancer return real-time monitoring system, cancer return real-time monitoring system comprises et al. Ke assembly 1 and external assembly 2, et al. Ke assembly 1 comprises circulation free RNA sensor 11, data processing module 12, first wireless communication module 13, data processing module 12 comprises input interface 121, microprocessor 122, output interface 123, reactor 124, input interface 121 receives electrochemical signals that the free RNA sensor 11 of circulation exports and input microprocessor 122 after it being converted into digital signal, is uploaded to external assembly 2 after microprocessor 122 pairs of digital signals carry out protocol conversion by output interface 123 via the first wireless communication module 13, external assembly 2 comprises data receiver 21, and data receiver 21 comprises controller 211, display 212, siren 213, second wireless communication module 214, controller 211 receives and analyzing body is implanted into circulation that assembly 1 uploads dissociates RNA signal, afterwards free for circulation RNA information is sent on display 212 and shows, the analysis programme of controller 211 arranges a threshold value, when this threshold value of horizontal exceeding of the free RNA that circulates, controller 211 sends instruction to described siren 213, siren 213 gives the alarm, notify that wearer notes the danger of cancer return, the control command of controller 211 passes on the reactor 124 in et al. Ke assembly 1 by the second wireless communication module 214, reactor 124 controlled circulation dissociates the unlatching of RNA sensor 11 or resting state, when dissociating 11 dormancy of RNA sensor when circulating, the free RNA sensor 11 of circulation is with negative electricity, association reaction is there is not with the RNA that dissociates of the circulation with negative electricity, when the free RNA sensor 11 that circulates is opened, the free RNA sensor 11 of circulation is not charged, association reaction is there is with the RNA that dissociates of the circulation with negative electricity, electronegative circulation RNA cause the circulating electrical conductivity of free RNA sensor 11 of dissociating changes, thus the concentration information of free for circulation RNA is converted into electrochemical signals.
Siren 213 is luminous organs, notifies that wearer notes the danger of cancer return by the mode of luminescence.
The described circulation RNA sensor 11 that dissociates comprises circulation free RNA trapping layer 111, hybridization signal inductive layer 112.Described circulation RNA trapping layer 111 of dissociating is made up of the capture probe with the free RNA specific binding of circulation.Capture probe is peptide nucleic acid(PNA) (PNA).
Hybridization signal inductive layer 112 comprises silicon nanowire array and forms.Hybridization signal inductive layer 112 is on the silicon nanowires utilizing conventional semiconductors technology to process, and is prepared from by silylation modification, surperficial unimolecule rete self assembly operation, fixes to form the free RNA sensor 11 of circulation through capture probe.The preparation process of the free RNA sensor 11 of circulation is well known to those skilled in the art.
First wireless communication module 13, second wireless communication module 214 adopts Zigbee protocol.
Data receiver 12 uses as in vitro accessory.
Controller 211 timing realizes the free unlatching of RNA sensor 11 of circulation or the control of dormancy.The interval time of continuously adjustabe between 1s to 1800s that control command is assigned, adjustment stepping is 2s.
Circulation in the present embodiment RNA that dissociates refers to circulation free mRNA.
The using method of above-mentioned implanted cancer return real-time monitoring system:
1, control implanted cancer return real-time monitoring system by controller 211 and be in resting state, et al. Ke assembly, with negative electricity (institute is electrically charged atomic weak, can not damage human body), is implanted subcutaneous by the free RNA sensor 11 of now circulation;
2, open implanted cancer return real-time monitoring system by controller 211, make the circulation RNA sensor 11 that dissociates not charged, the RNA that dissociates of the circulation now in tissue fluid can be combined with the free RNA sensor 11 of circulation;
3, after reacting certain hour, close implanted cancer return real-time monitoring system by controller 211 to make it again to be in resting state, the free RNA sensor 11 of now circulation is with negative electricity, the circulation combined with circulation free RNA sensor 11 in tissue fluid RNA and the circulation RNA sensor 11 that dissociates that dissociates is separated, and implanted cancer return real-time monitoring system is that detection is next time ready.
4, by observation display 212 display circulation dissociate RNA information and siren whether luminous, cancer patient knows whether cancer recurs.
Embodiment 3 one kinds of implanted cancer return real-time monitoring systems
A kind of implanted cancer return real-time monitoring system, cancer return real-time monitoring system comprises et al. Ke assembly 1 and external assembly 2, et al. Ke assembly 1 comprises circulation free RNA sensor 11, data processing module 12, first wireless communication module 13, data processing module 12 comprises input interface 121, microprocessor 122, output interface 123, reactor 124, input interface 121 receives electrochemical signals that the free RNA sensor 11 of circulation exports and input microprocessor 122 after it being converted into digital signal, is uploaded to external assembly 2 after microprocessor 122 pairs of digital signals carry out protocol conversion by output interface 123 via the first wireless communication module 13, external assembly 2 comprises data receiver 21, intelligent mobile terminal equipment 22, data receiver 21 comprises controller 211, display 212, siren 213, second wireless communication module 214, the 3rd wireless communication module 215, controller 211 receives and analyzing body is implanted into circulation that assembly 1 uploads dissociates RNA signal, afterwards free for circulation RNA information is sent on display 212 and shows, the analysis programme of controller 211 arranges a threshold value, when this threshold value of horizontal exceeding of the free RNA that circulates, controller 211 sends instruction to described siren 213, siren 213 gives the alarm, notify that wearer notes the danger of cancer return, the control command of controller 211 passes on the reactor 124 in et al. Ke assembly 1 by the second wireless communication module 214, reactor 124 controlled circulation dissociates the unlatching of RNA sensor 11 or resting state, when dissociating 11 dormancy of RNA sensor when circulating, the free RNA sensor of circulation is with negative electricity, association reaction is there is not with the RNA that dissociates of the circulation with negative electricity, when the free RNA sensor 11 that circulates is opened, the free RNA sensor of circulation is not charged, association reaction is there is with the RNA that dissociates of the circulation with negative electricity, electronegative circulation RNA cause the circulating electrical conductivity of free RNA sensor of dissociating changes, thus the concentration information of free for circulation RNA is converted into electrochemical signals.
Free for circulation RNA information is sent in intelligent mobile terminal equipment 22 by the 3rd wireless communication module 215 by controller 211.Intelligent mobile terminal equipment 22 carries out remote storage and analysis to the free RNA information of circulation.
Intelligent terminal 22 can be smart mobile phone, flat board or computer.
Data receiver 12 can be worn on any part of cancer patient's health, such as wrist.
First wireless communication module 13, second wireless communication module 214, the 3rd wireless communication module 215 adopt Bluetooth protocol.
Siren 213 is vibrators, notifies that wearer notes the danger of cancer return by the mode of vibration.
The free RNA sensor 11 of circulation comprises circulation free RNA trapping layer 111, hybridization signal inductive layer 112.The free RNA trapping layer 111 of circulation is made up of the capture probe with the free RNA specific binding of circulation.Capture probe is peptide nucleic acid(PNA) (PNA).
Hybridization signal inductive layer 112 comprises silicon nanowire array and forms.Hybridization signal inductive layer 112 is on the silicon nanowires utilizing conventional semiconductors technology to process, and is prepared from by silylation modification, surperficial unimolecule rete self assembly operation, fixes to form the free RNA sensor of circulation through capture probe.The preparation process of the free RNA sensor of circulation is well known to those skilled in the art.
Controller 211 timing realizes the free unlatching of RNA sensor of circulation or the control of dormancy.The interval time of continuously adjustabe between 1s to 1800s that control command is assigned, adjustment stepping is 2s.
Circulation in the present embodiment RNA that dissociates refers to circulating tumor miRNA.
The using method of above-mentioned implanted cancer return real-time monitoring system:
1, control implanted cancer return real-time monitoring system by controller 211 and be in resting state, et al. Ke assembly, with negative electricity (institute is electrically charged atomic weak, can not damage human body), is implanted subcutaneous by the free RNA sensor 11 of now circulation;
2, open implanted cancer return real-time monitoring system by controller 211, make the circulation RNA sensor 11 that dissociates not charged, the RNA that dissociates of the circulation now in tissue fluid can be combined with the free RNA sensor 11 of circulation;
3, after reacting certain hour, close implanted cancer return real-time monitoring system by controller 211 to make it again to be in resting state, the free RNA sensor 11 of now circulation is with negative electricity, the circulation combined with circulation free RNA sensor 11 in tissue fluid RNA and the circulation RNA sensor 11 that dissociates that dissociates is separated, and implanted cancer return real-time monitoring system is that detection is next time ready.
Whether 4, vibrated by the dissociate RNA information or intelligent mobile terminal equipment 22 and siren 213 of circulation of display on observation display 212, cancer patient knows whether cancer recurs.
Embodiment 4 one kinds of implanted cancer return real-time monitoring systems
A kind of implanted cancer return real-time monitoring system, cancer return real-time monitoring system comprises et al. Ke assembly 1 and external assembly 2, et al. Ke assembly 1 comprises circulation free RNA sensor 11, data processing module 12, first wireless communication module 13, data processing module 12 comprises input interface 121, microprocessor 122, output interface 123, reactor 124, input interface 121 receives electrochemical signals that the free RNA sensor 11 of circulation exports and input microprocessor 122 after it being converted into digital signal, is uploaded to external assembly 2 after microprocessor 122 pairs of digital signals carry out protocol conversion by output interface 123 via the first wireless communication module 13, external assembly 2 comprises data receiver 21, intelligent mobile terminal equipment 22, data receiver 21 comprises controller 211, display 212, siren 213, second wireless communication module 214, the 3rd wireless communication module 215, controller 211 receives and analyzing body is implanted into circulation that assembly 1 uploads dissociates RNA signal, afterwards free for circulation RNA information is sent on display 212 and shows, the analysis programme of controller 211 arranges a threshold value, when this threshold value of horizontal exceeding of the free RNA that circulates, controller 211 sends instruction to described siren 213, siren 213 gives the alarm, notify that wearer notes the danger of cancer return, the control command of controller 211 passes on the reactor 124 in et al. Ke assembly 1 by the second wireless communication module 214, reactor 124 controlled circulation dissociates the unlatching of RNA sensor 11 or resting state, when dissociating 11 dormancy of RNA sensor when circulating, the free RNA sensor of circulation is with negative electricity, association reaction is there is not with the RNA that dissociates of the circulation with negative electricity, when the free RNA sensor 11 that circulates is opened, the free RNA sensor of circulation is not charged, association reaction is there is with the RNA that dissociates of the circulation with negative electricity, electronegative circulation RNA cause the circulating electrical conductivity of free RNA sensor of dissociating changes, thus the concentration information of free for circulation RNA is converted into electrochemical signals.
Free for circulation RNA information is sent in intelligent mobile terminal equipment 22 by the 3rd wireless communication module 215 by controller 211.Intelligent mobile terminal equipment 22 carries out remote storage and analysis to the free RNA information of circulation.
Intelligent terminal 22 can be smart mobile phone, flat board or computer.
Data receiver 12 uses as in vitro accessory.
First wireless communication module 13, second wireless communication module 214, the 3rd wireless communication module 215 adopt Zigbee protocol.
Siren 213 is luminous organs, notifies that wearer notes the danger of cancer return by the mode of luminescence.
The free RNA sensor 11 of circulation comprises circulation free RNA trapping layer 111, hybridization signal inductive layer 112.The free RNA trapping layer 111 of circulation is made up of the capture probe with the free RNA specific binding of circulation.Capture probe is peptide nucleic acid(PNA) (PNA).
Hybridization signal inductive layer 112 comprises silicon nanowire array.Hybridization signal inductive layer 112 is on the silicon nanowires utilizing conventional semiconductors technology to process, and is prepared from by silylation modification, surperficial unimolecule rete self assembly operation, fixes to form the free RNA sensor 11 of circulation through capture probe.The preparation process of the free RNA sensor 11 of circulation is well known to those skilled in the art.
Controller 211 timing realizes the free unlatching of RNA sensor 11 of circulation or the control of dormancy.The interval time of continuously adjustabe between 1s to 1800s that control command is assigned, adjustment stepping is 2s.
Circulation in the present embodiment RNA that dissociates refers to circulation free mRNA.
The using method of above-mentioned implanted cancer return real-time monitoring system:
1, control implanted cancer return real-time monitoring system by controller 211 and be in resting state, et al. Ke assembly, with negative electricity (institute is electrically charged atomic weak, can not damage human body), is implanted subcutaneous by the free RNA sensor 11 of now circulation;
2, open implanted cancer return real-time monitoring system by controller 211, make the circulation RNA sensor 11 that dissociates not charged, the RNA that dissociates of the circulation now in tissue fluid can be combined with the free RNA sensor 11 of circulation;
3, after reacting certain hour, close implanted cancer return real-time monitoring system by controller 211 to make it again to be in resting state, the free RNA sensor 11 of now circulation is with negative electricity, the circulation combined with circulation free RNA sensor 11 in tissue fluid RNA and the circulation RNA sensor 11 that dissociates that dissociates is separated, and implanted cancer return real-time monitoring system is that detection is next time ready.
Whether 4, luminous by the dissociate RNA information or intelligent mobile terminal equipment 22 and siren 213 of circulation of display on observation display 212, cancer patient knows whether cancer recurs.
Although illustrate and described embodiment of the present utility model, those having ordinary skill in the art will appreciate that: can carry out multiple change, amendment, replacement and modification to these embodiments when not departing from principle of the present utility model and aim, scope of the present utility model is by claim and equivalents thereof.
Claims (3)
1. an implanted cancer return real-time monitoring system, is characterized in that, described monitoring system comprises et al. Ke assembly (1) and external assembly (2), described et al. Ke assembly (1) comprises circulation free RNA sensor (11), data processing module (12), the first wireless communication module (13), described data processing module (12) comprises input interface (121), microprocessor (122), output interface (123), reactor (124), described input interface (121) receives described circulation and to dissociate electrochemical signals that RNA sensor (11) exports input described microprocessor (122) after it is converted into digital signal, is uploaded to described external assembly (2) after described microprocessor (122) carries out protocol conversion to digital signal by described output interface (123) via described first wireless communication module (13), described external assembly (2) comprises data receiver (21), and described data receiver (21) comprises controller (211), display (212), siren (213), the second wireless communication module (214), described controller (211) receives and analyzes circulation that described et al. Ke assembly (1) uploads and to dissociate RNA signal, afterwards free for circulation RNA information is sent to the upper display of described display (212), the analysis programme of described controller (211) arranges a threshold value, when this threshold value of horizontal exceeding of the free RNA that circulates, described controller (211) sends instruction to described siren (213), described siren (213) gives the alarm, notify that wearer notes the danger of cancer return, the control command of described controller (211) passes on the described reactor (124) in described et al. Ke assembly (1) by described second wireless communication module (214), control described circulation to dissociate the unlatching of RNA sensor (11) or resting state.
2. monitoring system according to claim 1, it is characterized in that, described external assembly (2) also comprises intelligent mobile terminal equipment (22), described data receiver (21) also comprises the 3rd wireless communication module (215), and free for circulation RNA information is sent in described intelligent mobile terminal equipment (22) by described 3rd wireless communication module (215) by described controller (211).
3. monitoring system according to claim 1 and 2, is characterized in that, the described circulation RNA sensor (11) that dissociates comprises circulation free RNA trapping layer (111), hybridization signal inductive layer (112).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201520501397.2U CN204813902U (en) | 2015-07-12 | 2015-07-12 | Implanted cancer recurring real -time monitoring system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201520501397.2U CN204813902U (en) | 2015-07-12 | 2015-07-12 | Implanted cancer recurring real -time monitoring system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN204813902U true CN204813902U (en) | 2015-12-02 |
Family
ID=54671552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201520501397.2U Active CN204813902U (en) | 2015-07-12 | 2015-07-12 | Implanted cancer recurring real -time monitoring system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN204813902U (en) |
-
2015
- 2015-07-12 CN CN201520501397.2U patent/CN204813902U/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fridrichova et al. | MicroRNAs contribute to breast cancer invasiveness | |
| Wang et al. | Real-time, label-free monitoring of the cell cycle with a cellular impedance sensing chip | |
| CN109655512A (en) | A kind of excretion body detecting method based on aptamers and rolling circle amplification | |
| CN103409427B (en) | Aptamer EpCAM C of epithelial cell adhesion molecule and preparation method thereof | |
| Morotomi-Yano et al. | Nanosecond pulsed electric fields act as a novel cellular stress that induces translational suppression accompanied by eIF2α phosphorylation and 4E-BP1 dephosphorylation | |
| CN107049587A (en) | Intelligent menstrual cup | |
| Goyal et al. | Pre-determined diversity in resistant fates emerges from homogenous cells after anti-cancer drug treatment | |
| CN109295001A (en) | A kind of compound excretion body of umbilical cord mesenchymal stem cells and preparation method thereof | |
| Alghadeer et al. | Single-cell census of human tooth development enables generation of human enamel | |
| Min et al. | Biphasic electrical pulse by a micropillar electrode array enhances maturation and drug response of reprogrammed cardiac spheroids | |
| CN204813902U (en) | Implanted cancer recurring real -time monitoring system | |
| CN104939843A (en) | Implanted cancer relapse real-time monitoring system | |
| Moya-Ramírez et al. | Polymer encapsulation of bacterial biosensors enables coculture with mammalian cells | |
| Ghasemi et al. | MicroRNAs dysregulation as potential biomarkers for early diagnosis of endometriosis | |
| WO2004094610A3 (en) | Wnt as a factor for cardiac myogenesis | |
| CN105349403B (en) | A kind of preparation of electrically charged nanostructure cell chip and application process | |
| Xu et al. | A neural sensor with a nanocomposite interface for the study of Spike characteristics of hippocampal neurons under learning training | |
| CN109182507A (en) | For diagnosing blood plasma miRNA molecular marker, kit and its application of colorectal polypus | |
| CN110487877A (en) | A method of screening anti-trioxypurine small molecule compound | |
| Zhang et al. | Microswimmer-Assisted Dual-Signal Sensor for Multiple Targets in Whole Blood | |
| CN109266653A (en) | A kind of reagent, the device and method of the capture of drug resistance heterogeneity circulating tumor cell and genetic analysis | |
| Hsieh et al. | Emerging role of microRNA-200 family in dentistry | |
| CN103565783B (en) | The application in voltage gated k+ channel blocker agonist prepared by hexachlorophene | |
| CN105087794B (en) | One kind detects kit lungy | |
| Radenković et al. | Interstitial cells of Cajal–pacemakers of the intestinal musculature |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210413 Address after: 266000 room 2503, Qianshan building, D2, Qingdao International Innovation Park Phase II, No.1 Keyuan Weiyi Road, Laoshan District, Qingdao City, Shandong Province Patentee after: Qingdao Yangshen biomedical Co.,Ltd. Address before: 100080 3103, fangting building, No.1 Shanyuan street, Haidian District, Beijing Patentee before: BEIJING MEDINTELL BIOMED INFORMATION TECHNOLOGY Co.,Ltd. |
|
| TR01 | Transfer of patent right |